Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study.

<h4>Background</h4>In low-resource regions, fibrinolytic therapy is often the only option for ST-elevation myocardial infarction (STEMI) patients as primary percutaneous coronary intervention (PCI) is often not available and patients are hardly transferred to a medical center with PCI ca...

Full description

Bibliographic Details
Main Authors: Wuxiang Xie, Anushka Patel, Eric Boersma, Lin Feng, Min Li, Runlin Gao, Yangfeng Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0245576

Similar Items